SUMMARY Patients taking anti-inflammatory drugs for arthritis are prone to dyspepsia, and management of peptic ulcer is difficult because surgery is poorly tolerated. In this open study cimetidine treatment was associated with ulcer healing in 17 out of 21 patients with arthritis even when anti-inflammatory treatment was continued. Remission was maintained for 1 year by continued cimetidine therapy.
It is widely believed that patients with arthritis and similar conditions taking anti-inflammatory drugs have an increased incidence of dyspepsia and peptic ulceration. Evidence for this belief is poor except perhaps in patients with rheumatoid arthritis. However, when dyspeptic problems do occur in such patients, management often proves difficult. Patients are often elderly and frail and need the anti-inflammatory drugs which may be aggravating their condition. Many walk unhappily and unsteadily along a tightrope between the chasms of severe indigestion and severe joint pains.
Cimetidine is well established in the management of peptic ulceration in nonarthritic patients. We thus set out to perform controlled studies of its use in arthritic patients with dyspepsia taking antiinflammatory drugs. However, it soon became evident that cimetidine was effective. For this reason it was not clinically acceptable to allocate half the patients to placebo or alternative alkaline regimen when many had to continue with antiinflammatory drugs and had life-threatening lesions for which the alternative treatment was surgery, for which they were unfit. Thus this report concerns a series of patients treated carefully but openly with cimetidine.
Patients and methods
Twenty-three patients with arthritis and dyspepsia entered the study after endoscopic confirmation of either oesophagitis or gastric and duodenal ulceration. Six were identified by routine interview of 150 consecutive patients attending at rheumatology clinics; the remainder were referred in the usual way to the Gastrointestinal Unit. Two patients did not Accepted for publication 9 May 1979. Correspondence to Dr Croker.
complete the initial course of treatment. One was withdrawn after suffering a pathological fracture of the hip, and a second patient refused endoscopy. The remaining 18 females and 3 males have an average age of 63 years (range 37-83 years). Thirteen patients were suffering from rheumatoid arthritis, 12 having moderately active disease and 1 severe active disability. Six patients had osteoarthritis; the remaining 2 had Reiter's disease and psoriatic arthropathy.
Arthritis and dyspepsia began simultaneously in 5 patients, while in 10 patients arthritis antedated dyspepsia. Sixteen patients had previously associated dyspepsia with anti-inflammatory drugs. Eighteen patients previously and 9 at presentation were on multiple anti-inflammatory therapy (Table  1) .
Two patients with gastrointestinal bleeding and 1 patient with a perforated duodenal ulcer had previously received surgery. One other patient with a Maintenance. Maintenance therapy with cimetidine 400 mg twice daily was continued for 1 year in patients whose peptic lesions had healed. Oesophagitis was judged to have healed when inflammation had improved macroscopically together with symptomatic relief. Patients were reviewed monthly, and arthritis was assessed at 3-monthly intervals. Follow-up endoscopy was done at the end of 1 year or earlier if symptoms relapsed. The numbers in the study were small, and we could not show whether healing was influenced by anti-inflammatory drugs, smoking habits, age, inpatient treatment, or general health (Table 3) . Antiinflammatory treatment was continued in 12 out of 13 patients with rheumatoid arthritis, 1 out of 6 patients with osteoarthritis, and both remaining patients with Reiter's disease and psoriasis. Lesions healed in 10 of these 15 patients after 6 weeks of treatment.
Ulcers were unhealed in 6 patients, 5 of whom continued anti-inflammatory treatment. Repeat endoscopy was performed at 3 months in 5 patients after further therapy, with cimetidine 1 * 6 g per day.) Endoscopy showed healed duodenal ulcers in 2 patients but unhealed gastric ulcers in 3 patients. Further endoscopy was not considered appropriate in the remaining aged patient. Symptoms were completely controlled in 3 patients and improved in 3 others.
MAINTENANCE
Of the 17 patients whose peptic lesions healed 9 have completed 1 year's maintenance and 3 others have completed 6, 7, and 9 months respectively. In Cimetidine for peptic ulcer in patients with arthritis 277 5 other patients the maintenance period has been short (less than 6 months), but all patients remain asymptomatic.
Of the 12 patients who have completed prolonged periods of maintenance initial endoscopy showed oesophagitis in 4, gastric ulcers in 5, and duodenal ulcers in 3. Six patients were suffering from rheumatoid arthritis, 5 from osteoarthritis, and one from Reiter's disease. During the maintenance period anti-inflammatory drug therapywas continued unchanged in 4 patients but increased in 4 others. Four patients with osteoarthritis received no anti-inflammatory drugs during either the treatment or maintenance periods. Symptoms were controlled in 11 out of 12 patients, though 2 patients suffered minor dyspeptic relapses. In both these cases repeat endoscopy showed normal appearances. Final endoscopy at the completion of maintenance treatment gave normal results in those 11 asymptomatic patients. One patient with rheumatoid arthritis and oesophagitis relapsed both clinically and endoscopically when anti-inflammatory treatment was increased. One year later on full dose of cimetidine 1 6 g/day she remains symptomatically well, and repeat endoscopy showed minimal oesophagitis only.
Of the 4 patients whose ulcers did not heal in the initial treatment period 2 have remained asymptomatic on maintenance cimetidine 400 mg nocte. The 2 remaining patients have continued to have dyspeptic problems, particularly when attempts were made to increase anti-inflammatory treatment.
Side effects. No side effects attributable to cimetidine were noted during either the treatment or maintenance periods.
Laboratory measurements. Abnormal findings were common, but no new abnormalities developed during treatment or maintenance with cimetidine.
Compliance. Patient compliance for cimetidine was high when judged by tablet count and diary records.
Discussion
The exact frequency of peptic ulceration in rheumatoid patients is difficult to assess. In a review of the literature (Cooke (1967) found a large range but concluded that the frequency was probably increased. In fact we were surprised by the small number of patients referred with dyspeptic problems from a busy rheumatology unit. Figures may vary according to the method of detection, and endoscopic studies have shown a high frequency of ulceration in asymptomatic patients (Sun et al., 1974) . In this study only symptomatic patients were investigated. Little information is available documenting peptic ulceration in nonrheumatoid arthritis.
The increased frequency of peptic ulceration, if real, may simply reflect the general poor health which is common in these patients. It is known that serious illness is associated with peptic ulceration. In this series the general health of the patients was less than satisfactory in 13, and 7 patients had significant complicating medical illness.
Any effect of the arthritis is difficult to separate from the action of anti-inflammatory drugs, and assessment of individual drugs is complicated by the multiplicity of them commonly given. All 16 patients who associated dyspepsia with antiinflammatory treatment did so while taking more than 1 drug.
Although most anti-inflammatory drugs have produced gastric lesions in various animal models (Brodie et al., 1962; Davenport 1969; Robert and Nazamis, 1963; Chvasta and Cooke, 1972; Mann and Sachdev, 1976) there is little convincing information in man. Epidemiological studies have indicated an increased frequency of gastric ulcer with heavy use of aspirin (Duggan and Chapman, 1970; Levy, 1974) but not with steroids (Conn and Blitzer, 1976) . Endoscopic studies have shown that damage to the gastric mucosa may be caused not only by aspirin (Weiss etal., 1961) but also by indomethacin, phenylbutazone, and propionic acid derivatives (Lanza et al., 1975; Lehtola and Sipponen, 1977) . The damage caused by aspirin is acid-dependent (Davenport, 1969) . Although acid secretion studies were not performed on any of the patients studied, none were suffering from pernicious anaemia. The numbers in this trial were small and it would require vast numbers to separate the possible effect of various factors on ulcer healing (Tables 2 and 3 ). For these reasons it is impossible to form any definite conclusion of the prime contribution of cimetidine therapy. Overall, however, the results are good. During the treatment study healing occurred in 15 out of 21 patients at 6 weeks and 17 out of 21 at 3 months. Eleven of these 17 patients continued to take anti-inflammatory drugs. Patients with rheumatoid arthritis did less well than those with osteoarthritis, healing occurring in 9 out of 13 by 3 months in the former and 6 out of 6 in the latter. Patients with rheumatoid arthritis, however, were less well generally and anti-inflammatory drugs were continued in 12 out of 13 compared to 1 out of 6 with osteoarthritis. 
